Human Papillomavirus Testing Market
The Human Papillomavirus (HPV) Testing market consists of diagnostic tests, instruments, and consumables used to detect the HPV virus, a primary cause of cervical cancer. Key customers include hospitals, clinics, and laboratories that perform routine cancer screenings, primarily for women's health. Market growth is propelled by rising awareness of HPV's link to cancer, the implementation of national screening programs, and technological advancements like more sensitive assays and self-sampling kits.
CAGR
12.2%
Compound Annual Growth Rate
Current Value
$2.21B
Estimated 2026
Projected Value
$5.55B
By 2034